Trials / Completed
CompletedNCT05174780
Myopia Control With a Innovative Spectacle Lens
Clinical Evaluation of A Innovative Spectacle Lens in Slowing Myopia Progression
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 159 (actual)
- Sponsor
- Essilor International · Industry
- Sex
- All
- Age
- 6 Years – 12 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to demonstrate that the test spectacle lens is safe and effective in slowing myopia progression in children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | innovative myopia control spectacle lens | using a innovative spectacle lens to control myopia progression |
| DEVICE | Single vision spectacle lens | single vision spectacle lens for myopia and astigmatism correction |
Timeline
- Start date
- 2021-12-29
- Primary completion
- 2025-10-20
- Completion
- 2025-10-20
- First posted
- 2022-01-03
- Last updated
- 2025-12-22
Locations
9 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05174780. Inclusion in this directory is not an endorsement.